Bioregenx (BRGX) Non-Current Debt (2021 - 2026)
Bioregenx (BRGX) recorded quarterly Non-Current Debt of $182564.0 in Q1 2026, down 84.59% quarter-over-quarter from $1.2 million in Q4 2025, and down 29.02% on a YoY basis from $257220.0 in Q1 2025.
Bioregenx (BRGX) Non-Current Debt (2021 - 2026) Analysis & Trends
Bioregenx's Non-Current Debt history runs 6 years deep, the most recent figure standing at $182564.0 for Q1 2026.
- In Q1 2026, Non-Current Debt fell 29.02% year-over-year to $182564.0; the TTM figure through Mar 2026 stood at $182564.0 (down 29.02% YoY), while the FY2025 annual figure was $1.2 million, up 365.44% from the prior year.
- Non-Current Debt was $182564.0 for Q1 2026 at Bioregenx, down from $1.2 million in the prior quarter.
- In the past five years, Non-Current Debt ranged from a high of $1.2 million in Q4 2025 to a low of $181069.0 in Q3 2025.
- Historically, Non-Current Debt has averaged $515865.5 across 5 years, with a median of $257220.0 in 2025.
- The sharpest annual moves came in 2024 and 2025: Non-Current Debt jumped 461.98% in 2024, then plunged 74.26% in 2025.
- A 5-year view of Non-Current Debt shows it stood at $195811.0 in 2022, then jumped by 168.46% to $525681.0 in 2023, then tumbled by 51.57% to $254606.0 in 2024, then soared by 365.44% to $1.2 million in 2025, then tumbled by 84.59% to $182564.0 in 2026.
- The last three Non-Current Debt figures came in at $182564.0 (Q1 2026), $1.2 million (Q4 2025), and $181069.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 24.83 Bn | 17.52 Bn | 662.02 Mn | - |
| 2 | BrightSpring Health Services | 13.57 Bn | 12.69 Bn | 482.22 Mn | 2.44 Bn |
| 3 | Healthequity | 7.20 Bn | 6.93 Bn | 256.31 Mn | 942.66 Mn |
| 4 | Hinge Health | 5.42 Bn | 5.11 Bn | 154.23 Mn | - |
| 5 | 10x Genomics | 4.46 Bn | 3.92 Bn | 106.18 Mn | - |
| 6 | Doximity | 3.81 Bn | 3.06 Bn | 125.97 Mn | - |
| 7 | Waystar Holding | 3.52 Bn | 3.36 Bn | 268.04 Mn | 1.46 Bn |
| 8 | Privia Health | 2.94 Bn | 2.57 Bn | 595.71 Mn | - |
| 9 | Omnicell | 1.76 Bn | 1.59 Bn | 140.36 Mn | - |
| 10 | Bioregenx | - | - | 348,288.00 | 182,564.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 182,564.00 |
| Mar 31, 2026 | 182,564.00 |
| Dec 31, 2025 | 1.19 Mn |
| Dec 31, 2025 | 1.19 Mn |
| Sep 30, 2025 | 181,069.00 |
| Sep 30, 2025 | 181,069.00 |
| Jun 30, 2025 | 1.15 Mn |
| Jun 30, 2025 | 1.15 Mn |
| Mar 31, 2025 | 257,220.00 |
| Mar 31, 2025 | 257,220.00 |
| Dec 31, 2024 | 254,606.00 |
| Dec 31, 2024 | 254,606.00 |
| Sep 30, 2024 | 282,260.00 |
| Sep 30, 2024 | 282,260.00 |
| Jun 30, 2024 | 1.10 Mn |
| Jun 30, 2024 | 1.10 Mn |
| Mar 31, 2024 | 999,491.00 |
| Mar 31, 2024 | 999,491.00 |
| Dec 31, 2023 | 525,681.00 |
| Dec 31, 2023 | 525,681.00 |